Company / CapEx per Share
Prime Medicine, Inc. CapEx per Share History
FY2020-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest CapEx per Share
$0.06
FY2024
5-year range
$0.06 / $0.47
FY2020-FY2024
Trend
-35.9%
vs FY2023
Sector context
#69 of 191
Health Care
What the data says
At $0.06, Prime Medicine, Inc.'s capex per share ranks #69 of 191 in the Health Care sector. Declined from $0.47 to $0.06 over the past 2 years.
Based on SEC 10-K filings.
0.06 in FY2024 with a 3-year CAGR of -42.3%.
Declined from $0.47 to $0.06 over the past 2 years.
Health Care sector context is included.
CapEx per Share over time
Growth rates
- 3-Year CAGR
- -42.3%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#69 of 191 in Health CareTop 36% of 191This company $0.06 Sector average $4.05
▼
-98.5% below sector average
Key checks
Key Insights
- In FY2024, capex per share decreased 35.9% year-over-year.
- Ranks #69 out of 191 companies in the Health Care sector.
- Peak capex per share was recorded in FY2022.
Company context
Key Data Points
- Altman Z-Score -1.24 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | CapEx per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $0.06 | -35.9% |
| FY2023 | $0.10 | -79.8% |
| FY2022 | $0.47 | +48.5% |
| FY2021 | $0.32 | +32.1% |
| FY2020 | $0.24 | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026